A 58-year-old man with a 3-month history of hematuria and flank pain undergoes CT imaging of the abdomen. A large renal mass is identified with the characteristic yellow-tan appearance of clear cell renal cell carcinoma. The structure marked **C** in the diagram shows invasion into the renal vein with tumor thrombus formation. Which of the following statements best describes the surgical and staging implications of this finding?

Explanation

## Why option 1 is right Renal vein invasion with tumor thrombus (marked **C**) is a hallmark finding in advanced renal cell carcinoma that classifies the tumor as T3a according to AJCC 8th edition staging (T3 = invasion of renal vein/IVC/Gerota fascia). This finding has critical surgical implications: it necessitates IVC thrombectomy in addition to radical nephrectomy, and preoperative imaging with CT or MRI is essential to define the extent of thrombus and plan the operative approach. The presence of renal vein invasion does NOT preclude surgery—rather, it mandates careful preoperative assessment and coordination with vascular surgery. This is a key gross pathological feature of clear cell RCC that directly impacts treatment strategy (Harrison 21e Ch 88). ## Why each distractor is wrong - **Option 2**: Renal vein invasion alone does NOT constitute metastatic disease (M1). T3a disease is locally advanced but potentially curable with surgery. Systemic immunotherapy may be used adjuvantly (e.g., pembrolizumab per KEYNOTE-564) after surgery, but surgery remains the cornerstone of treatment for T3 disease. - **Option 3**: Renal vein invasion is not a contraindication to partial nephrectomy per se, but it does make partial nephrectomy technically unfeasible and unsafe, necessitating radical nephrectomy. Chemotherapy is not the primary treatment for locally advanced RCC; surgery with possible adjuvant immunotherapy is standard. - **Option 4**: The clinical presentation (yellow-tan mass, renal vein invasion) is characteristic of clear cell RCC, not papillary RCC. Papillary RCC is associated with MET mutations (Type 1) or HLRCC (Type 2), and the gross appearance differs. Clear cell RCC is the most common subtype (~75%) and has a different prognosis and genetic basis (VHL mutation on chromosome 3p25) than papillary variants. **High-Yield:** Renal vein/IVC tumor thrombus in RCC = T3a/b/c staging; mandates IVC thrombectomy; requires preoperative imaging; surgical resection remains curative intent treatment, not a contraindication. [cite: Harrison 21e Ch 88]